Categories Consumer, Earnings

Wall St hits bulls-eye with Colgate-Palmolive Q2 estimates

Consumer goods company Colgate-Palmolive (NYSE: CL) on Friday reported second-quarter results that were in line with the Wall Street projections.

Q2 revenues of $3.87 billion, which were almost flat year-over-year, were hurt by higher raw material and advertising costs, as well as currency headwinds. Analysts had projected Q2 revenues of $3.88 billion.

Earnings, on an adjusted basis, fell 6% to 72 cents per share, in line with the street estimates.

Q2 revenues of $3.87 billion, which were almost flat year-over-year, were hurt by higher raw material and advertising costs,

Colgate stock gained 1% following the announcement of the results. CL shares have gained 22% so far this year.

READ: Alphabet reverses ad revenue deceleration trend in Q2, stock rises

In North America, despite revenues increasing 2.5% year-over-year, operating profits were down 4%. This was primarily due to higher raw and packaging material costs, partially offset by cost savings from the company’s funding-the-growth initiatives.

CEO Noel Wallace said, “Colgate’s leadership of the global toothpaste market continued during the quarter with our global market share at 41.4% year to date. Our global leadership in manual toothbrushes also continued with Colgate’s global market share in that category at 31.7% year to date.”

Outlook

The company continues to expect 2019 net sales to be flat to up low-single-digits, with organic sales up between 2% and 4%. Excluding certain one-time costs, Colgate continue to plan for a year of gross margin expansion, increased advertising investment and a mid-single-digit decline in earnings per share.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

WBA Earnings Preview: Will Walgreens’ Q3 report bring cheer to investors?

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) has been facing challenges due to higher operating costs, rising competition, and an unfavorable retail environment. These factors have put pressure on the drugstore

Main points from Accenture’s (ACN) Q3 2024 earnings report

Shares of Accenture (NYSE: ACN) rose 6% on Thursday, following the company’s announcement of its third-quarter 2024 earnings results. Although revenue and profits missed expectations, the stock jumped after the

ACB Earnings: Aurora Cannabis reports narrower Q4 loss on higher revenues

Aurora Cannabis, Inc. (NASDAQ: ACB) on Thursday reported a net loss for the fourth quarter of 2024. The company’s revenues moved up 5% year-over-year during the quarter. The Canada-based recreational

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top